Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

EXAS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 17, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Exact Sciences Corp (EXAS)

Based on 29 analysts giving stock ratings to Exact Sciences Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
7
Buy
21
Hold
72
Sell
0
Strong Sell
0
Exact Sciences Corp

Exact Sciences Corp. Stock Analysis EXAS

United States Health Care Large Cap Report:
EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 7,100 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Read More

Exact Sciences Corp (EXAS) Chart

Key Statistics of Exact Sciences Corp (EXAS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$104.90$104.98

Today's Open

$104.93

Volume

21.56M

P/E Ratio (TTM)

-

52 Week Range

$38.81$104.98

Market Cap

19.72B

Avg. Volume

3.02M

Dividend Yield

-

Financial Metrics & Statements of Exact Sciences Corp (EXAS)

FAQ's for Exact Sciences Corp (EXAS)

  • According to Musaffa’s Shariah screening methodology, Exact Sciences Corp (EXAS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Exact Sciences Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Exact Sciences Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Exact Sciences Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Exact Sciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Exact Sciences Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.